263 related articles for article (PubMed ID: 24577455)
1. The Italian Alzheimer's Disease Neuroimaging Initiative (I-ADNI): validation of structural MR imaging.
Cavedo E; Redolfi A; Angeloni F; Babiloni C; Lizio R; Chiapparini L; Bruzzone MG; Aquino D; Sabatini U; Alesiani M; Cherubini A; Salvatore E; Soricelli A; Vernieri F; Scrascia F; Sinforiani E; Chiarati P; Bastianello S; Montella P; Corbo D; Tedeschi G; Marino S; Baglieri A; De Salvo S; Carducci F; Quattrocchi CC; Cobelli M; Frisoni GB
J Alzheimers Dis; 2014; 40(4):941-52. PubMed ID: 24577455
[TBL] [Abstract][Full Text] [Related]
2. Standardization of hippocampus volumetry using automated brain structure volumetry tool for an initial Alzheimer's disease imaging biomarker.
Abrigo J; Shi L; Luo Y; Chen Q; Chu WCW; Mok VCT;
Acta Radiol; 2019 Jun; 60(6):769-776. PubMed ID: 30185071
[TBL] [Abstract][Full Text] [Related]
3. Hippocampal volume change measurement: quantitative assessment of the reproducibility of expert manual outlining and the automated methods FreeSurfer and FIRST.
Mulder ER; de Jong RA; Knol DL; van Schijndel RA; Cover KS; Visser PJ; Barkhof F; Vrenken H;
Neuroimage; 2014 May; 92():169-81. PubMed ID: 24521851
[TBL] [Abstract][Full Text] [Related]
4. Fully Automated Atlas-Based Hippocampus Volumetry for Clinical Routine: Validation in Subjects with Mild Cognitive Impairment from the ADNI Cohort.
Suppa P; Hampel H; Spies L; Fiebach JB; Dubois B; Buchert R;
J Alzheimers Dis; 2015; 46(1):199-209. PubMed ID: 25720402
[TBL] [Abstract][Full Text] [Related]
5. Differential diagnosis of mild cognitive impairment and Alzheimer's disease using structural MRI cortical thickness, hippocampal shape, hippocampal texture, and volumetry.
Sørensen L; Igel C; Pai A; Balas I; Anker C; Lillholm M; Nielsen M;
Neuroimage Clin; 2017; 13():470-482. PubMed ID: 28119818
[TBL] [Abstract][Full Text] [Related]
6. Performance of Hippocampus Volumetry with FSL-FIRST for Prediction of Alzheimer's Disease Dementia in at Risk Subjects with Amnestic Mild Cognitive Impairment.
Suppa P; Hampel H; Kepp T; Lange C; Spies L; Fiebach JB; Dubois B; Buchert R;
J Alzheimers Dis; 2016; 51(3):867-73. PubMed ID: 26923010
[TBL] [Abstract][Full Text] [Related]
7. Magnetic resonance imaging in Alzheimer's Disease Neuroimaging Initiative 2.
Jack CR; Barnes J; Bernstein MA; Borowski BJ; Brewer J; Clegg S; Dale AM; Carmichael O; Ching C; DeCarli C; Desikan RS; Fennema-Notestine C; Fjell AM; Fletcher E; Fox NC; Gunter J; Gutman BA; Holland D; Hua X; Insel P; Kantarci K; Killiany RJ; Krueger G; Leung KK; Mackin S; Maillard P; Malone IB; Mattsson N; McEvoy L; Modat M; Mueller S; Nosheny R; Ourselin S; Schuff N; Senjem ML; Simonson A; Thompson PM; Rettmann D; Vemuri P; Walhovd K; Zhao Y; Zuk S; Weiner M
Alzheimers Dement; 2015 Jul; 11(7):740-56. PubMed ID: 26194310
[TBL] [Abstract][Full Text] [Related]
8. Manual segmentation qualification platform for the EADC-ADNI harmonized protocol for hippocampal segmentation project.
Duchesne S; Valdivia F; Robitaille N; Mouiha A; Valdivia FA; Bocchetta M; Apostolova LG; Ganzola R; Preboske G; Wolf D; Boccardi M; Jack CR; Frisoni GB;
Alzheimers Dement; 2015 Feb; 11(2):161-74. PubMed ID: 25617509
[TBL] [Abstract][Full Text] [Related]
9. The pilot European Alzheimer's Disease Neuroimaging Initiative of the European Alzheimer's Disease Consortium.
Frisoni GB; Henneman WJ; Weiner MW; Scheltens P; Vellas B; Reynish E; Hudecova J; Hampel H; Burger K; Blennow K; Waldemar G; Johannsen P; Wahlund LO; Zito G; Rossini PM; Winblad B; Barkhof F;
Alzheimers Dement; 2008 Jul; 4(4):255-64. PubMed ID: 18631976
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic differentiation of mild cognitive impairment due to Alzheimer's disease using a hippocampus-dependent test of spatial memory.
Moodley K; Minati L; Contarino V; Prioni S; Wood R; Cooper R; D'Incerti L; Tagliavini F; Chan D
Hippocampus; 2015 Aug; 25(8):939-51. PubMed ID: 25605659
[TBL] [Abstract][Full Text] [Related]
11. Training labels for hippocampal segmentation based on the EADC-ADNI harmonized hippocampal protocol.
Boccardi M; Bocchetta M; Morency FC; Collins DL; Nishikawa M; Ganzola R; Grothe MJ; Wolf D; Redolfi A; Pievani M; Antelmi L; Fellgiebel A; Matsuda H; Teipel S; Duchesne S; Jack CR; Frisoni GB;
Alzheimers Dement; 2015 Feb; 11(2):175-83. PubMed ID: 25616957
[TBL] [Abstract][Full Text] [Related]
12. Harmonized benchmark labels of the hippocampus on magnetic resonance: the EADC-ADNI project.
Bocchetta M; Boccardi M; Ganzola R; Apostolova LG; Preboske G; Wolf D; Ferrari C; Pasqualetti P; Robitaille N; Duchesne S; Jack CR; Frisoni GB;
Alzheimers Dement; 2015 Feb; 11(2):151-60.e5. PubMed ID: 25223727
[TBL] [Abstract][Full Text] [Related]
13. Operationalizing protocol differences for EADC-ADNI manual hippocampal segmentation.
Boccardi M; Bocchetta M; Ganzola R; Robitaille N; Redolfi A; Duchesne S; Jack CR; Frisoni GB;
Alzheimers Dement; 2015 Feb; 11(2):184-94. PubMed ID: 23706515
[TBL] [Abstract][Full Text] [Related]
14. Basal forebrain atrophy correlates with amyloid β burden in Alzheimer's disease.
Kerbler GM; Fripp J; Rowe CC; Villemagne VL; Salvado O; Rose S; Coulson EJ;
Neuroimage Clin; 2015; 7():105-13. PubMed ID: 25610772
[TBL] [Abstract][Full Text] [Related]
15. Diurnal fluctuations in brain volume: Statistical analyses of MRI from large populations.
Nakamura K; Brown RA; Narayanan S; Collins DL; Arnold DL;
Neuroimage; 2015 Sep; 118():126-32. PubMed ID: 26049148
[TBL] [Abstract][Full Text] [Related]
16. MarkVCID cerebral small vessel consortium: II. Neuroimaging protocols.
Lu H; Kashani AH; Arfanakis K; Caprihan A; DeCarli C; Gold BT; Li Y; Maillard P; Satizabal CL; Stables L; Wang DJJ; Corriveau RA; Singh H; Smith EE; Fischl B; van der Kouwe A; Schwab K; Helmer KG; Greenberg SM;
Alzheimers Dement; 2021 Apr; 17(4):716-725. PubMed ID: 33480157
[TBL] [Abstract][Full Text] [Related]
17. Sample Size Estimation for Alzheimer's Disease Trials from Japanese ADNI Serial Magnetic Resonance Imaging.
Fujishima M; Kawaguchi A; Maikusa N; Kuwano R; Iwatsubo T; Matsuda H; ;
J Alzheimers Dis; 2017; 56(1):75-88. PubMed ID: 27911297
[TBL] [Abstract][Full Text] [Related]
18. Fully Automatic MRI-Based Hippocampus Volumetry Using FSL-FIRST: Intra-Scanner Test-Retest Stability, Inter-Field Strength Variability, and Performance as Enrichment Biomarker for Clinical Trials Using Prodromal Target Populations at Risk for Alzheimer's Disease.
Cavedo E; Suppa P; Lange C; Opfer R; Lista S; Galluzzi S; Schwarz AJ; Spies L; Buchert R; Hampel H; ;
J Alzheimers Dis; 2017; 60(1):151-164. PubMed ID: 28777748
[TBL] [Abstract][Full Text] [Related]
19. AddNeuroMed and ADNI: similar patterns of Alzheimer's atrophy and automated MRI classification accuracy in Europe and North America.
Westman E; Simmons A; Muehlboeck JS; Mecocci P; Vellas B; Tsolaki M; Kłoszewska I; Soininen H; Weiner MW; Lovestone S; Spenger C; Wahlund LO; ;
Neuroimage; 2011 Oct; 58(3):818-28. PubMed ID: 21763442
[TBL] [Abstract][Full Text] [Related]
20. The AddNeuroMed framework for multi-centre MRI assessment of Alzheimer's disease: experience from the first 24 months.
Simmons A; Westman E; Muehlboeck S; Mecocci P; Vellas B; Tsolaki M; Kłoszewska I; Wahlund LO; Soininen H; Lovestone S; Evans A; Spenger C
Int J Geriatr Psychiatry; 2011 Jan; 26(1):75-82. PubMed ID: 21157852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
